Hengehold Capital Management LLC acquired a new stake in UnitedHealth Group Inc (NYSE:UNH) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 1,025 shares of the healthcare conglomerate’s stock, valued at approximately $301,000.
Other institutional investors have also recently made changes to their positions in the company. Johanson Financial Advisors Inc. raised its position in shares of UnitedHealth Group by 28,935.9% during the 4th quarter. Johanson Financial Advisors Inc. now owns 3,384,419 shares of the healthcare conglomerate’s stock valued at $11,512,000 after acquiring an additional 3,372,763 shares in the last quarter. California Public Employees Retirement System boosted its holdings in UnitedHealth Group by 15.0% in the third quarter. California Public Employees Retirement System now owns 3,356,394 shares of the healthcare conglomerate’s stock worth $729,412,000 after purchasing an additional 437,189 shares during the period. Boston Partners boosted its holdings in UnitedHealth Group by 160.8% in the second quarter. Boston Partners now owns 2,550,998 shares of the healthcare conglomerate’s stock worth $622,942,000 after purchasing an additional 1,572,711 shares during the period. California State Teachers Retirement System increased its stake in UnitedHealth Group by 1.3% during the third quarter. California State Teachers Retirement System now owns 1,722,879 shares of the healthcare conglomerate’s stock valued at $374,416,000 after purchasing an additional 21,293 shares during the last quarter. Finally, Barrow Hanley Mewhinney & Strauss LLC increased its stake in UnitedHealth Group by 63.3% during the second quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 1,705,888 shares of the healthcare conglomerate’s stock valued at $416,254,000 after purchasing an additional 661,064 shares during the last quarter. 85.79% of the stock is owned by hedge funds and other institutional investors.
UnitedHealth Group stock traded down $6.54 during midday trading on Friday, reaching $292.92. 318,533 shares of the stock traded hands, compared to its average volume of 3,071,641. The company has a current ratio of 0.69, a quick ratio of 0.70 and a debt-to-equity ratio of 0.61. The firm has a fifty day moving average price of $291.61 and a two-hundred day moving average price of $257.23. The firm has a market cap of $284.78 billion, a price-to-earnings ratio of 20.43, a PEG ratio of 1.47 and a beta of 0.65. UnitedHealth Group Inc has a fifty-two week low of $208.07 and a fifty-two week high of $302.54.
In related news, CAO Thomas E. Roos sold 1,177 shares of the stock in a transaction that occurred on Thursday, November 7th. The stock was sold at an average price of $255.04, for a total value of $300,182.08. Following the completion of the transaction, the chief accounting officer now directly owns 21,687 shares of the company’s stock, valued at approximately $5,531,052.48. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP D Ellen Wilson sold 7,400 shares of the stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $272.77, for a total value of $2,018,498.00. Over the last quarter, insiders have sold 23,577 shares of company stock valued at $6,810,430. Insiders own 0.87% of the company’s stock.
UNH has been the topic of a number of recent research reports. Evercore ISI initiated coverage on shares of UnitedHealth Group in a research report on Tuesday, December 10th. They issued a “buy” rating and a $285.00 price target on the stock. Barclays reaffirmed a “buy” rating on shares of UnitedHealth Group in a report on Sunday, January 19th. Credit Suisse Group boosted their price objective on shares of UnitedHealth Group from $320.00 to $330.00 and gave the company an “outperform” rating in a research report on Wednesday, January 8th. SunTrust Banks increased their price objective on shares of UnitedHealth Group from $335.00 to $350.00 and gave the stock a “buy” rating in a research note on Wednesday, December 18th. Finally, Mizuho reissued a “buy” rating and issued a $300.00 target price (up previously from $270.00) on shares of UnitedHealth Group in a report on Tuesday, November 26th. Five research analysts have rated the stock with a hold rating and nineteen have given a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $313.50.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Read More: What is the definition of arbitrage?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.